MFG
UTHR icon

Merit Financial Group’s United Therapeutics UTHR Stock Holding History

Merit Financial Group’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.34M Sell
9,856
-246
-2% -$139K 0.03% 415
2026
Q1 		$5.99M Sell
10,102
-635
-6% -$316K 0.04% 347
2025
Q4 		$5.23M Buy
10,737
+3,321
+45% +$1.55M 0.04% 356
2025
Q3 		$3.11M Buy
7,416
+2,672
+56% +$899K 0.03% 432
2025
Q2 		$1.36M Buy
4,744
+1,401
+42% +$419K 0.02% 651
2025
Q1 		$1.03M Sell
3,343
-120
-3% -$41.1K 0.02% 642
2024
Q4 		$1.22M Buy
3,463
+927
+37% +$341K 0.02% 460
2024
Q3 		$909K Buy
2,536
+690
+37% +$233K 0.02% 448
2024
Q2 		$588K Buy
+1,846
New +$489K 0.01% 545

Other funds holding UTHR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM

Merit Financial Group's UTHR Position: Q2 2026 in Review

Merit Financial Group reduced its United Therapeutics (UTHR) stake by 2.4% in Q2 2026, selling an estimated $139K and leaving 9,856 shares worth $5.34M. The position accounts for 0.03% of the portfolio, ranked #415.

Merit Financial Group first reported a position in UTHR in Q2 2024 and has held it in 9 quarters since. The position peaked at $5.99M in Q1 2026. 880 funds tracked by Wall St. Rank hold UTHR as of Q2 2026.

  • Merit Financial Group held 9,856 shares of United Therapeutics worth $5.34M as of Q2 2026.
  • Merit Financial Group sold 246 United Therapeutics shares in Q2 2026, an estimated $139K.
  • United Therapeutics made up 0.03% of Merit Financial Group's portfolio in Q2 2026, its #415 holding.
  • Merit Financial Group first reported a position in United Therapeutics in Q2 2024 and has held it in 9 quarters since.
  • Merit Financial Group's United Therapeutics position peaked at $5.99M in Q1 2026.
  • 880 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2026.

Based on Merit Financial Group's 13F filing for Q2 2026, filed 17 Jul 2026.